UNGUENT OFTALMIC
UNGUENT OFTALMIC
Suspended
- Oxytetracycline hydrochloride
- Dexamethasone phosphate
- Lidocaine hydrochloride
Product identification
Medicine name:
UNGUENT OFTALMIC
Active substance:
- Oxytetracycline hydrochloride
- Dexamethasone phosphate
- Lidocaine hydrochloride
Target species:
-
Horse
-
Dog
-
Cat
-
Rabbit
-
Pigeon
-
Ornamental bird
-
Reptile
Route of administration:
-
Ocular use
Product details
Active substance and strength:
-
Oxytetracycline hydrochloride20.00/milligram(s)1.00gram(s)
-
Dexamethasone phosphate1.00/milligram(s)1.00gram(s)
-
Lidocaine hydrochloride5.00/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Ointment
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QS01AA04
- QS01BA01
- QS01HA07
Legal status of supply:
This information is not available for this product.
Authorisation status:
-
Suspended
Authorised in:
-
Romania
Package description:
- Available only in Romanian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
- Romvac Company S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Romvac Company S.A.
Responsible authority:
- Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
- 150483
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Romanian (PDF)
Published on: 12/07/2022